The University of Pittsburgh Graduate School of Public Health will participate in a study that could hasten the day when a patient’s genetic profile, not trial and error, helps a doctor determine which medications to prescribe.

Genetic factors determine how a patient responds to a medication. A person may get better results from one drug than another. People also metabolize drugs at different rates, so some require smaller doses than others.

The 28-month, $350,000 study will enroll about 400 volunteers with mental-health disorders who are clients of NHS Human Services in Allegheny, Beaver, Dauphin and Lehigh counties. The study is funded by the Polk Foundation, Downtown.

Researchers will analyze genetic material from about half of the volunteers and use those insights to make medication adjustments aimed at optimizing drug performance and decreasing side effects and adverse drug interactions, said Dietrich Stephan, professor and chairman of Pitt’s Department of Human Genetics, who will head the study’s clinical advisory panel.

Advertise with us

The other volunteers, serving as a control group, will receive their usual care.

The researchers foresee a time when doctors routinely consult a patient’s genetic profile to select medications and determine the correct dosage. While that’s already done with certain cancer patients, standard practice is for a doctor to prescribe a medication and, if it yields inadequate results or produces intolerable side effects, change the dose or switch to another drug.

“It’s an inefficient process,” Mr. Stephan said.

Most drugs work correctly in only about half of the people who take them, said Michael Christman, president and CEO of Coriell Institute for Medical Research in Camden, N.J. The institute’s for-profit arm, Coriell Life Sciences, is providing genetic testing and interpretation for the study.

If a drug fails to work, treatment is delayed, said Kevin Bain, vice president of medication risk mitigation at CareKinesis Inc., the Moorestown, N.J., firm providing analysis for the study.

Advertise with us

Side effects and adverse drug interactions pose additional risks. Mr. Stephan said one group of researchers found that 1 million people are hospitalized annually because of adverse drug interactions and that as many as 106,000 of them die.

Mr. Stephan said the coming study focuses on patients with mental-health disorders because they take multiple medications, rendering them especially vulnerable to adverse reactions. He envisions a second study focusing on the elderly, another vulnerable group.

Deb Burock, senior corporate director of NHS Human Services, said her agency is participating because of the “potential to really improve the quality of life of the people that we serve ... We want to find a more effective means of supporting these individuals.”  Kim Sonafelt, who oversees the agency’s programs in various counties, said clients in Allegheny and Beaver counties take an average of 10 medications each.

The falling cost of genetic testing and medicine’s increasing focus on personalized medicine support a genetics-based approach to medication management, said Mr. Christman and Scott Megill, president and CEO of Coriell Life Sciences. Tests costs $500 or less, Mr. Megill said, with Medicare and some private insurers providing coverage.

The research “is definitely needed,” said Kathi Elliott, a psychiatric nurse practitioner at Adaptive Behavioral Services in East Liberty, who struggles to “tease out” the most appropriate medications and doses for patients presenting complex symptoms. She is not involved in the study.

Advertise with us

Ms. Elliott, who has a doctor of nursing practice degree, said she uses a thorough patient assessment, including family history with psychiatric drugs, to help narrow medication choices. Because many people are reluctant to seek help for mental-health issues, she said, she worries about discouraging patients if medications don’t work as expected.

Kirstyn Kameg, professor of nursing and coordinator of the psychiatric mental health nurse practitioner program at Robert Morris University, said psychiatric medications may cause fatigue, anxiety, sexual problems or other issues. A person who has a bad experience, she said, may withdraw from treatment.

“You may lose them as a patient,” said Ms. Kameg, who is not involved in the study.

Joe Smydo: jsmydo@post-gazette.com or 412-263-1548.